Cargando…
Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021
Persistent high-risk human papillomavirus (HPV) infection is the pivotal cause of cervical carcinogenesis. HPV types distribution varies greatly by region, and its long-term changes of prevalence remain to be fully characterized in China. Here, the largest population of 198,111 consecutive women who...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936994/ https://www.ncbi.nlm.nih.gov/pubmed/36744409 http://dx.doi.org/10.1080/22221751.2023.2176009 |
_version_ | 1784890339979427840 |
---|---|
author | Yang, Xiaohan Li, Yuanyuan Tang, Yuan Li, Zhiyu Wang, Sanfeng Luo, Xiping He, Tianwen Yin, Aihua Luo, Mingyong |
author_facet | Yang, Xiaohan Li, Yuanyuan Tang, Yuan Li, Zhiyu Wang, Sanfeng Luo, Xiping He, Tianwen Yin, Aihua Luo, Mingyong |
author_sort | Yang, Xiaohan |
collection | PubMed |
description | Persistent high-risk human papillomavirus (HPV) infection is the pivotal cause of cervical carcinogenesis. HPV types distribution varies greatly by region, and its long-term changes of prevalence remain to be fully characterized in China. Here, the largest population of 198,111 consecutive women who underwent routine cervical screening were investigated from 2015 to 2021 in Guangzhou, south China. The results showed that the overall HPV prevalence was 21.66% (42,911/198,111), and the annual prevalence increased significantly from 2015 to 2021 (p < 0.001). HPV52, 16, 58, CP8304, 51, 53, 39, and 68 were the most prevalent HPV types. The relative HPV-positive rate correlated positively with the progression of cervical intraepithelial neoplasia (p < 0.001); HPV16 was the predominant carcinogenic type, followed by HPV52 and HPV18. HPV infections were significantly age-specific, and 26.51% (11,375/42,911) of cases were caused by multiple HPV types. In addition, HPV infections typically cleared over a median time of 16 (interquartile range 9–31) months, and the clearance of HPV16 was significantly faster than that of other types (p < 0.001). These findings may serve as a guide for local governments to evaluate HPV vaccination and cervical cancer prevention strategies in south China. |
format | Online Article Text |
id | pubmed-9936994 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-99369942023-02-18 Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021 Yang, Xiaohan Li, Yuanyuan Tang, Yuan Li, Zhiyu Wang, Sanfeng Luo, Xiping He, Tianwen Yin, Aihua Luo, Mingyong Emerg Microbes Infect Research Article Persistent high-risk human papillomavirus (HPV) infection is the pivotal cause of cervical carcinogenesis. HPV types distribution varies greatly by region, and its long-term changes of prevalence remain to be fully characterized in China. Here, the largest population of 198,111 consecutive women who underwent routine cervical screening were investigated from 2015 to 2021 in Guangzhou, south China. The results showed that the overall HPV prevalence was 21.66% (42,911/198,111), and the annual prevalence increased significantly from 2015 to 2021 (p < 0.001). HPV52, 16, 58, CP8304, 51, 53, 39, and 68 were the most prevalent HPV types. The relative HPV-positive rate correlated positively with the progression of cervical intraepithelial neoplasia (p < 0.001); HPV16 was the predominant carcinogenic type, followed by HPV52 and HPV18. HPV infections were significantly age-specific, and 26.51% (11,375/42,911) of cases were caused by multiple HPV types. In addition, HPV infections typically cleared over a median time of 16 (interquartile range 9–31) months, and the clearance of HPV16 was significantly faster than that of other types (p < 0.001). These findings may serve as a guide for local governments to evaluate HPV vaccination and cervical cancer prevention strategies in south China. Taylor & Francis 2023-02-15 /pmc/articles/PMC9936994/ /pubmed/36744409 http://dx.doi.org/10.1080/22221751.2023.2176009 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Yang, Xiaohan Li, Yuanyuan Tang, Yuan Li, Zhiyu Wang, Sanfeng Luo, Xiping He, Tianwen Yin, Aihua Luo, Mingyong Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021 |
title | Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021 |
title_full | Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021 |
title_fullStr | Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021 |
title_full_unstemmed | Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021 |
title_short | Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021 |
title_sort | cervical hpv infection in guangzhou, china: an epidemiological study of 198,111 women from 2015 to 2021 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936994/ https://www.ncbi.nlm.nih.gov/pubmed/36744409 http://dx.doi.org/10.1080/22221751.2023.2176009 |
work_keys_str_mv | AT yangxiaohan cervicalhpvinfectioninguangzhouchinaanepidemiologicalstudyof198111womenfrom2015to2021 AT liyuanyuan cervicalhpvinfectioninguangzhouchinaanepidemiologicalstudyof198111womenfrom2015to2021 AT tangyuan cervicalhpvinfectioninguangzhouchinaanepidemiologicalstudyof198111womenfrom2015to2021 AT lizhiyu cervicalhpvinfectioninguangzhouchinaanepidemiologicalstudyof198111womenfrom2015to2021 AT wangsanfeng cervicalhpvinfectioninguangzhouchinaanepidemiologicalstudyof198111womenfrom2015to2021 AT luoxiping cervicalhpvinfectioninguangzhouchinaanepidemiologicalstudyof198111womenfrom2015to2021 AT hetianwen cervicalhpvinfectioninguangzhouchinaanepidemiologicalstudyof198111womenfrom2015to2021 AT yinaihua cervicalhpvinfectioninguangzhouchinaanepidemiologicalstudyof198111womenfrom2015to2021 AT luomingyong cervicalhpvinfectioninguangzhouchinaanepidemiologicalstudyof198111womenfrom2015to2021 |